Amgen Wins Halt of Copies for Blockbuster Otezla Until 2028 (1) – Bloomberg Law

A proposed copy by Cadila Healthcare Ltd. ‘s Zydus unit would infringe a patent that expires in February 2028 and covers the drug’s composition, …